Deol Madhvi, Taylor David A, Radcliffe Nathan M
aWeill Medical College, Cornell University bReichert Inc., Depew cDepartment of Ophthalmology, NYU School of Medicine, New York, USA.
Curr Opin Ophthalmol. 2015 Mar;26(2):96-102. doi: 10.1097/ICU.0000000000000130.
Glaucoma is a leading cause of irreversible blindness worldwide. It is estimated that roughly 60.5 million people had glaucoma in 2010 and that this number is increasing. Many patients continue to lose vision despite apparent disease control according to traditional risk factors. The purpose of this review is to discuss the recent findings with regard to corneal hysteresis, a variable that is thought to be associated with the risk and progression of glaucoma.
Low corneal hysteresis is associated with optic nerve and visual field damage in glaucoma and the risk of structural and functional glaucoma progression. In addition, hysteresis may enhance intraocular pressure (IOP) interpretation: low corneal hysteresis is associated with a larger magnitude of IOP reduction following various glaucoma therapies. Corneal hysteresis is dynamic and may increase in eyes after IOP-lowering interventions are implemented.
It is widely accepted that central corneal thickness is a predictive factor for the risk of glaucoma progression. Recent evidence shows that corneal hysteresis also provides valuable information for several aspects of glaucoma management. In fact, corneal hysteresis may be more strongly associated with glaucoma presence, risk of progression, and effectiveness of glaucoma treatments than central corneal thickness.
青光眼是全球不可逆性失明的主要原因。据估计,2010年约有6050万人患有青光眼,且这一数字正在上升。尽管根据传统危险因素疾病似乎得到了控制,但许多患者仍继续丧失视力。本综述的目的是讨论关于角膜滞后的最新研究结果,这一变量被认为与青光眼的风险和进展相关。
低角膜滞后与青光眼患者的视神经和视野损害以及青光眼结构和功能进展的风险相关。此外,滞后可能增强眼压(IOP)的解读:低角膜滞后与各种青光眼治疗后眼压降低的幅度更大相关。角膜滞后是动态的,在实施降低眼压干预措施后,眼睛的角膜滞后可能会增加。
普遍认为中央角膜厚度是青光眼进展风险的预测因素。最近的证据表明,角膜滞后在青光眼管理的几个方面也提供了有价值的信息。事实上,与中央角膜厚度相比,角膜滞后可能与青光眼的存在、进展风险和青光眼治疗效果的关联更为密切。